Top 10 Risk Adjustment Platforms for Smarter Value-Based Care

This is my hands-on evaluation of 10 risk adjustment platforms for value-based care teams preparing for 2026 Medicare Advantage, or MA, and accountable care organization, or ACO, contracts.

My scoring centered on capture quality, compliance, provider workflow, pricing, integration speed, and fit for different contracting mixes.

With 54% of eligible Medicare beneficiaries now enrolled in Medicare Advantage and federal payments projected at roughly $590.9 billion in 2026, accurate risk capture is now a core operating task. Risk Adjustment Data Validation, or RADV, extrapolation is active for payment year 2018 forward, and CMS-HCC v28 moves to 100% in 2026. Platforms now need to be defensible, provider-friendly, and fast to deploy.

Key Takeaways

These are the practical themes that separated strong platforms from weaker ones.

• RAAPID is the top overall pick for AI-first risk adjustment. It combines point-of-care suspecting with retrospective coding QA, uses natural language processing, or NLP, for Hierarchical Condition Category, or HCC, discovery, and produces RADV-ready audit trails.
• Provider-first tools like Vatica Health and Curation Health improve documentation inside the visit. They reduce after-visit chart chasing by guiding clinicians while the encounter is still active.
• Payer-scale platforms like Cotiviti and Inovalon lead in data plumbing and audit prep. They are strongest in chart retrieval, enterprise analytics, and high-volume retrospective review.
• Expect hybrid pricing models. Most vendors mix per-member-per-month, or PMPM, software fees with per-chart review charges and optional services for retrieval or provider training.
• Validate CMS-HCC v28 mapping and RADV evidence export before you sign. The 2024 CMS-HCC model includes 115 HCCs and 7,770 ICD-10 codes. Over 95% of the roughly 2,000 codes removed from payment were tied to ICD-10 remapping.
• Pilot fast. Ninety days is enough to measure suspect precision, clinician adoption, and risk adjustment factor, or RAF, movement if the workflow is well designed.

How I Tested These Platforms

Capture quality mattered most, but compliance and usability decided the close calls.

I scored every platform across six core areas that map to the daily work of MA plans, ACOs, and delegated groups.

• Data ingestion: EHR feeds, Fast Healthcare Interoperability Resources, or FHIR, Release 4 APIs, HL7 messages, Continuity of Care Documents, or CCDs, claims, and social determinants of health, or SDoH, feeds.
• Prospective suspecting quality: Precision and recall on HCC candidates surfaced before or during the visit.
• Provider UX: Low-friction prompts aligned to ICD-10-CM documentation rules.
• Retrospective coding: Workbench speed, dual-coder quality assurance, or QA, and explainability of NLP evidence.
• Compliance and auditability: v28 mapping updates, audit trails, coder rationale capture, and RADV evidence export.
• Analytics: Gap closure tracking, variance reporting, and RAF movement attribution.

Scoring weights were 40% capture quality, 20% compliance, 15% provider UX, 10% integration speed, 10% analytics, and 5% commercials. I also favored tools that could explain why a suspect appeared, not just that it appeared.

What Is Risk Adjustment?

Risk adjustment matches payment to patient complexity.

It uses demographics and HCC diagnosis groups to predict expected cost, so plans and providers are not penalized for caring for sicker populations.

RAF is the score that drives per-member revenue. Prospective capture happens before or during the visit, while retrospective capture happens after the encounter through chart review. RADV is the CMS audit program that tests whether submitted diagnoses are supported by the record.

Why 2026 Changes Everything

The 2026 model shift makes stale workflows expensive.

CMS proposes to complete the three-year phase-in of the updated 2024 CMS-HCC model in calendar year 2026 by calculating 100% of MA risk scores with that model. It was rebuilt using ICD-10 diagnoses and newer fee-for-service data from 2018 and 2019, with clinical expert input meant to improve predictive accuracy.

The biggest impact on risk scores and revenue comes from ICD-10 remapping and updated data years, with smaller effects from clinical updates. RADV extrapolation is now codified for payment year 2018 forward. ICD-10-CM guidelines also prohibit coding diagnoses documented as probable, suspected, or rule-out, so every suspect a platform surfaces must trace back to supported clinical documentation.

Types of Risk Adjustment Platforms

The right platform type depends on where your bottleneck sits, in the visit, in coding, or in chart retrieval.

Payer-First Platforms

These tools are strongest in retrospective review, large-scale data ingestion, and actuarial analytics. They fit MA plans and delegated groups with in-house coding teams that need national chart retrieval, centralized governance, and deep reporting.

Provider-First Platforms

These tools place suspecting and documentation prompts inside clinician workflow. They work best for ACOs, clinic-led MA contracts, and groups that want to capture conditions during the encounter instead of chasing charts weeks later.

Hybrid and Full-Service Platforms

These vendors combine software with managed services such as coding, retrieval, and provider education. They make sense for lean teams, new programs, and organizations that need fast lift before annual submission deadlines.

1. RAAPID

RAAPID is the best fit for teams that want one AI-first risk adjustment platform across prospective capture, coding QA, and audit defense.

RAAPID Pros

• AI-first blend of prospective suspecting and retrospective coding QA powered by NLP-driven HCC discovery
• Flexible ingestion across EHR feeds, FHIR R4, claims, and scanned charts
• Explainable evidence that links each suspect to the source clinical note
• RADV-ready audit trails with clear provenance to original documentation
• Fast pilot path for both Medicare Advantage and ACO teams

RAAPID Cons

• AI-driven workflow changes still require provider and coder adoption work
• You should confirm FHIR resource support and security attestations in your BAA before go-live

My Experience With RAAPID

RAAPID stood out because it covers the full risk adjustment cycle instead of only one part of it. On the prospective side, it surfaces HCC suspects at the point of care so clinicians can document supported conditions during the visit. On the retrospective side, coders get a workbench that shows candidate conditions beside the exact note evidence that supports or refutes them.

That explains why explainability matters. Peer-reviewed research shows NLP can identify HCC-related conditions from clinical notes, but production teams still need a human review layer they can defend in an audit. RAAPID makes that review practical because coders are not asked to trust a black box.

For teams that want one system across suspecting, coding QA, and evidence packaging, RAAPID felt more complete than a point solution. If your records include a high share of scanned charts, expect some cleanup work early, but the payoff is a cleaner workflow as v28 becomes the full model.

RAAPID Price

Expect a software-plus-services model. Common structures include hybrid PMPM fees, per-reviewed-chart pricing, and optional implementation support. Negotiate service-level agreements around suspect precision, turnaround time, and audit evidence export. 

For Medicare Advantage and ACO teams facing CMS-HCC v28, needing chart ingestion, NLP-driven HCC discovery, coder workflows, and defensible evidence in one workflow, this risk adjustment platform deserves a serious evaluation.

2. Cotiviti

Cotiviti is strongest for payer-scale operations that need data depth, governance, and mature retrospective review.

Cotiviti Pros

• Enterprise-grade data ingestion and analytics with deep payer heritage
• Mature retrospective review workflows and strong actuarial reporting

Cotiviti Cons

• Implementation can take longer, and provider-facing UX is lighter than point-of-care-first tools

My Experience With Cotiviti

Cotiviti fits plans and delegated groups that need scale across chart retrieval, coding operations, and leadership reporting. Its reporting depth was especially useful for finance and actuarial teams tracking RAF variance and submission readiness.

Cotiviti Price

Pricing usually comes through enterprise licensing with bundled services. Clarify per-chart economics during peak review periods, especially before submission deadlines.

3. Apixio

Apixio is a strong pick when coding productivity and explainable retrospective AI matter more than in-visit nudging.

Apixio Pros

• Advanced NLP and machine learning for HCC identification with strong QA workflows

Apixio Cons

• It relies on clean document normalization, and provider prompts are lighter than dedicated point-of-care tools

My Experience With Apixio

Apixio works well for teams focused on coder throughput and explainable AI in retrospective review. When document feeds are clean, the workbench can move cases quickly without losing traceability.

Apixio Price

Expect subscription pricing with volume tiers. Make sure model governance terms address v28 mapping updates and retraining cadence.

4. Inovalon

Inovalon is best for organizations that need national retrieval capacity and broad data assets.

Inovalon Pros

• Broad data assets, established review pipelines, and national-scale chart retrieval infrastructure

Inovalon Cons

• The product portfolio is broad, so scope control matters early

My Experience With Inovalon

Inovalon makes sense for plans that need retrieval at scale, large coding operations, and dashboard-driven oversight. Provider UX is not its main strength, so it works best when retrospective workflows already drive the program.

Inovalon Price

Expect a platform-plus-services model. Tie incentives to defect rates, turnaround times, and retrieval completion.

5. Vatica Health

Vatica Health stands out when the main goal is better documentation during the encounter.

Vatica Health Pros

• Point-of-care enablement with clinician-friendly templates and strong prospective capture during visits

Vatica Health Cons

• Retrospective depth depends on complementary systems, so confirm RADV evidence export

My Experience With Vatica Health

Vatica reduces after-visit rework by helping providers capture better documentation at the source. It still needs a disciplined provider engagement plan, because even good prompts fail if clinicians view them as extra clicks.

Vatica Health Price

Pricing is often PMPM with adoption support. Ask for provider training milestones, launch benchmarks, and clear expectations for refresh cycles.

6. Curation Health

Curation Health is a solid option for provider groups that want strong in-visit suspecting without heavy service layers.

Curation Health Pros

• Prospective suspecting with provider prompts mapped to documentation guidelines and strong FHIR and HL7 integration

Curation Health Cons

• Retrospective throughput depends on your own coding bench, so confirm multi-EHR support

My Experience With Curation Health

Curation Health fits value-focused provider groups that want better in-visit performance without a large services contract. If you buy it for outcomes, tie success measures to closed gaps and supported capture, not just reviewed volume.

Curation Health Price

Expect subscription pricing with enablement services. Outcome-based clauses can help keep incentives aligned after go-live.

7. Episource

Episource works well for lean teams that need software plus flexible review capacity.

Episource Pros

• Balanced software-plus-services model with chart retrieval, coder QA, and education programs

Episource Cons

• Prospective nudging needs extra configuration, and handoffs can multiply during peak season

My Experience With Episource

Episource is useful when you need turnkey capacity now and a path to bring work in-house later. Its service depth helps smaller teams absorb seasonal spikes without building a full internal operation.

Episource Price

Volume-based rate cards are common. Negotiate overflow pricing and audit support separately so costs stay predictable.

8. Edifecs

Edifecs is a strong fit for organizations that want tighter model governance and data control.

Edifecs Pros

• Mature software lineage with model management, analytics, and payer-provider flexibility

Edifecs Cons

• Implementation takes rigor, so align on data models and v28 mapping specifics early

My Experience With Edifecs

Edifecs suits organizations with internal data engineering teams that want precise mapping control. It is less forgiving if your source data is messy or your governance process is loose.

Edifecs Price

Expect enterprise licensing. Clarify which connectors, QA modules, and reporting packages are included in the base agreement.

9. Centauri Health Solutions

Centauri Health Solutions is best for teams that want services-first support with software underneath.

Centauri Health Solutions Pros

• Services-forward model with software support, member outreach, retrieval capacity, and coder QA

Centauri Health Solutions Cons

• Product depth varies by module, so confirm evidence capture against your audit standards

My Experience With Centauri Health Solutions

Centauri is useful for plans ramping quickly into a mixed software and services model. Contract discipline matters here, because vague performance terms can turn into uneven delivery later.

Centauri Health Solutions Price

Pricing blends software and services fees. Build performance guarantees into the agreement wherever you can.

10. Optum

Optum makes sense for large enterprises that want broad connectivity and end-to-end module coverage.

Optum Pros

• Broad data and connectivity footprint with modules spanning retrieval, coding, and analytics

Optum Cons

• Portfolio complexity means you need clear scope, module ownership, and audit artifact terms

My Experience With Optum

Optum is suited to large organizations that want ecosystem reach and multiple operating options. Tight governance is essential, because overlapping modules and unclear ownership can create cost creep and slower execution.

Optum Price

Expect enterprise agreements with per-module service levels. Confirm security obligations and audit artifact ownership in your BAA.

FAQ

These questions come up most often when teams move from basic coding review to a full platform for risk adjustment.

What Is CMS-HCC v28, and Why Does It Matter in 2026?

CMS-HCC v28 is the updated risk adjustment model rebuilt on ICD-10 diagnoses and newer fee-for-service data. In 2026, CMS will calculate 100% of MA risk scores with this model. Organizations that do not remap their capture logic and coding rules risk both revenue leakage and audit exposure.

How Does AI in Value-Based Care Improve Capture Without Encouraging Upcoding?

Compliant tools surface suspect conditions only when the record shows supporting clinical evidence. ICD-10-CM guidelines prohibit coding probable or suspected diagnoses. The best platforms link each candidate to the source note so coders can confirm or reject it with clear rationale.

What Evidence Do Auditors Expect in RADV?

Auditors expect a clear path from the submitted HCC back to the source clinical note. Strong platforms can export evidence packets with highlighted note text, coding rationale, and change logs for each reviewed condition.

Do We Need Both Prospective and Retrospective Capture?

Yes. Prospective capture improves documentation quality during the visit, while retrospective review finds missed conditions and checks coding accuracy. Strong programs run both at the same time.

How Do FHIR APIs Change Integration Speed?

ONC’s Cures Act Final Rule established standardized FHIR-based APIs and information-blocking provisions. Platforms that support FHIR R4 can connect to certified EHRs faster, which can shorten pilot timelines from months to weeks and improve portability.

How Do We Keep Providers From Alert Fatigue?

Default-on prompts inside the normal visit workflow work better than separate dashboards. Limit prompts to high-confidence suspects, keep education short, and show the logic behind each recommendation so clinicians can trust it.